BDKRB1 and ovarian carcinoma: Quantitative real-time polymerase chain reaction (qRT-PCR) was further performed to validate BDKRB1 expression in ovarian cancer cell lines.<h4>Results</h4>BDKRB1 was consistently overexpressed in ovarian cancer and associated with unfavorable clinical outcomes across multiple cohorts.